Showing results (411-420 of 734) with videos related to

Sort By:
Pageof 74
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2012
Development of a human monoclonal antibody for potential therapy of CD27-expressing lymphoma and leukemiaLaura A Vitale, Li-Zhen He, Lawrence J Thomas, et al.
Leukemia & Lymphoma|July 7, 2007
Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasoneLijo Simpson, Stephen M Ansell, Joseph P Colgan, et al.
Blood|January 5, 2002
Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphomaStephen M Ansell, Thomas E Witzig, Paul J Kurtin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemiaJames R Cerhan, Celine M Vachon, Thomas M Habermann, et al.
Blood|December 24, 2014
Durable remissions in a pivotal phase 2 study of brentuximab vedotin in relapsed or refractory Hodgkin lymphomaAjay K Gopal, Robert Chen, Scott E Smith, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectClaire M Vajdic, Ola Landgren, Mary L McMaster, et al.
Cardio-Oncology (London, England)|December 21, 2024
Baseline echocardiographic variables as predictors of hemodynamically significant cytokine release syndrome in adults treated with CD19 CAR T-cell therapy for hematological malignanciesAndres E Daryanani, Muhannad A Abbasi, Maria F Gomez Ardila, et al.
Plos One|May 27, 2016
Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph NodeHristina Nedelkovska, Alexander F Rosenberg, Shannon P Hilchey, et al.
American Journal of Hematology|June 8, 2012
Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patientsStephen M Ansell, Matthew J Maurer, Steven C Ziesmer, et al.
Pageof 74